Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poole

Showing results (541-550 of 1,034) with videos related to

Pageof 104
Sort By:
Food Additives and Contaminants|January 26, 2005
Review of the toxicology, human exposure and safety assessment for bisphenol A diglycidylether (BADGE)A Poole, P van Herwijnen, H Weideli, et al.
Journal of the American College of Cardiology|January 1, 1990
Pulmonary artery pressure changes during exercise and daily activities in chronic heart failureJ S Gibbs, J Keegan, C Wright, et al.
British Heart Journal|July 1, 1977
Haemodynamic effects of salbutamol and nitroprusside after cardiac surgeryP A Poole-Wilson, G Lewis, T Angerpointer, et al.
Journal of Chemical Information and Modeling|April 22, 2025
Computational Strategies for Broad Spectrum Venom Phospholipase A<sub>2</sub> InhibitorsDavid A Poole, Laura-Oana Albulescu, Jeroen Kool, et al.
Circulation|June 1, 1996
Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonistS Kaddoura, J D Firth, K R Boheler, et al.
The Veterinary Record|July 24, 2001
Systemic bioavailability of erythromycin in cattle when applied by footbathB J Hartog, S H Tap, H J Pouw, et al.
European Journal of Pharmacology|February 11, 1992
Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitroC W Jiang, P M Sarrel, D C Lindsay, et al.
Postgraduate Medical Journal|February 1, 1995
ACE inhibitors in heart failure. What dose?J G Cleland, W N Hubbard, J Pittard, et al.
Journal of Bacteriology|February 1, 1987
Effect of growth phase on phospholipid biosynthesis in Saccharomyces cerevisiaeM J Homann, M A Poole, P M Gaynor, et al.
Cardiology|November 3, 2007
Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trialsRichard M Lewis, David J Gordon, Philip A Poole-Wilson, et al.
Pageof 104

Showing results (541-550 of 1,034) with videos related to

Sort By:
Pageof 104
Food Additives and Contaminants|January 26, 2005
Review of the toxicology, human exposure and safety assessment for bisphenol A diglycidylether (BADGE)A Poole, P van Herwijnen, H Weideli, et al.
Journal of the American College of Cardiology|January 1, 1990
Pulmonary artery pressure changes during exercise and daily activities in chronic heart failureJ S Gibbs, J Keegan, C Wright, et al.
British Heart Journal|July 1, 1977
Haemodynamic effects of salbutamol and nitroprusside after cardiac surgeryP A Poole-Wilson, G Lewis, T Angerpointer, et al.
Journal of Chemical Information and Modeling|April 22, 2025
Computational Strategies for Broad Spectrum Venom Phospholipase A<sub>2</sub> InhibitorsDavid A Poole, Laura-Oana Albulescu, Jeroen Kool, et al.
Circulation|June 1, 1996
Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonistS Kaddoura, J D Firth, K R Boheler, et al.
The Veterinary Record|July 24, 2001
Systemic bioavailability of erythromycin in cattle when applied by footbathB J Hartog, S H Tap, H J Pouw, et al.
European Journal of Pharmacology|February 11, 1992
Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitroC W Jiang, P M Sarrel, D C Lindsay, et al.
Postgraduate Medical Journal|February 1, 1995
ACE inhibitors in heart failure. What dose?J G Cleland, W N Hubbard, J Pittard, et al.
Journal of Bacteriology|February 1, 1987
Effect of growth phase on phospholipid biosynthesis in Saccharomyces cerevisiaeM J Homann, M A Poole, P M Gaynor, et al.
Cardiology|November 3, 2007
Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trialsRichard M Lewis, David J Gordon, Philip A Poole-Wilson, et al.
Pageof 104